Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
650
-
Total 13F shares, excl. options
-
87.6M
-
Shares change
-
-1.38M
-
Total reported value, excl. options
-
$18.4B
-
Value change
-
-$308M
-
Put/Call ratio
-
0.39
-
Number of buys
-
276
-
Number of sells
-
-317
-
Price
-
$209.63
Significant Holders of RESMED INC - COM (RMD) as of Q2 2022
749 filings reported holding RMD - RESMED INC - COM as of Q2 2022.
RESMED INC - COM (RMD) has 650 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.6M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (16.1M shares), BlackRock Inc. (13.3M shares), STATE STREET CORP (6.43M shares), WCM INVESTMENT MANAGEMENT, LLC (6.42M shares), Capital World Investors (4.49M shares), GEODE CAPITAL MANAGEMENT, LLC (2.98M shares), NORTHERN TRUST CORP (2.03M shares), Invesco Ltd. (1.65M shares), Ownership Capital B.V. (1.6M shares), and Bank of New York Mellon Corp (1.29M shares).
This table shows the top 650 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.